Literature DB >> 28138380

Treatment Options of Streptococcal Pharyngitis in Infancy.

Davood Kheirkhah1, Alireza Sharif2.   

Abstract

Entities:  

Keywords:  Pharyngitis; Streptococcus pyogenes; Treatment Protocols

Year:  2016        PMID: 28138380      PMCID: PMC5240158          DOI: 10.5812/jjm.41798

Source DB:  PubMed          Journal:  Jundishapur J Microbiol        ISSN: 2008-3645            Impact factor:   0.747


× No keyword cloud information.
Dear Editor, Recently, we read with interest the case report by Sharif et al. entitled “Streptococcal pharyngitis in a two-month-old infant: a case report” published in Jundishapur journal of microbiology (1). Streptococcal pharyngitis, as reported in their manuscript, is rare among children less than 1 year old and there are no clear instructions regarding the treatment of infant patients suffering from this condition. The main goals of antimicrobial therapy for eradication of group A beta-hemolytic streptococcus (GABHS) pharyngitis are reducing severity and duration of acute signs and symptoms, lowering the incidence of nonsuppurative complications and reducing the transmission rat (2). In this case the patient has been treated with intramuscular penicillin benzathine G because of poor feeding and significant illness; however, this is not the only treatment choice (1). Antimicrobial resistance has not been a significant issue in the treatment of GABHS pharyngitis and several treatment options are available (3, 4). The drug of choice is oral penicillin V that has appropriate effects, narrow spectrum, low cost and easy consumption. However, similar to intramuscular penicillin no exact dosing is available for this drug in infants, so that the only prescription parameter is weighing less or greater than 27 kg (5, 6). Compare to intramuscular penicillin, oral penicillin V is less effective in the prevention of acute rheumatic fever, so nowadays this method is used less frequently (5, 6). In this case oral Amoxicillin seems to be an appropriate treatment option because of accurate dosage (50 mg/kg/day for 10 days), better gastrointestinal absorption and better activity against other causative pathogens (4, 7). Other available antimicrobial agents against GABHS pharyngitis are Cephalexin (25-50 mg/kg/day for 10 days), Azithromycin (12 mg/kg/dose for first day followed by 6 mg/kg/dose for days 2 through 5), Clarithromycin (7.5 mg/kg/dose for 10 days) and Clindamycin (7 mg/kg /dose for 10 days) (2, 4). In conclusion, antimicrobial therapy against GABHS pharyngitis is not limited to penicillin’s family and there are a lot of options to treat infants with GABHS pharyngitis. Therefore, we believe that this case could be treated with a wider range of oral antibiotics.
  6 in total

Review 1.  Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication.

Authors:  Malcolm Gillies; Anggi Ranakusuma; Tammy Hoffmann; Sarah Thorning; Treasure McGuire; Paul Glasziou; Christopher Del Mar
Journal:  CMAJ       Date:  2014-11-17       Impact factor: 8.262

2.  Group A streptococcus colonies from a single throat swab can have heterogeneous antimicrobial susceptibility patterns.

Authors:  Aurélie Vandevoorde; Sabrina Ascenzo; Veronique Yvette Miendje Deyi; Georges Mascart; Anne-Laure Mansbach; Marguerite Landsberg; Pierre Dreze; Andrew C Steer; Laurence Van Melderen; Pierre R Smeesters
Journal:  Pediatr Infect Dis J       Date:  2013-03       Impact factor: 2.129

Review 3.  Different antibiotic treatments for group A streptococcal pharyngitis.

Authors:  Mieke L van Driel; An Im De Sutter; Hilde Habraken; Sarah Thorning; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2016-09-11

4.  Guideline for the management of acute sore throat.

Authors:  C Pelucchi; L Grigoryan; C Galeone; S Esposito; P Huovinen; P Little; T Verheij
Journal:  Clin Microbiol Infect       Date:  2012-04       Impact factor: 8.067

5.  Streptococcal Pharyngitis in a Two-Month-Old Infant: A Case Report.

Authors:  Mohammad Reza Sharif; Marzieh Aalinezhad; Seyyed Mohammad Sajad Sajadian; Mostafa Haji Rezaei
Journal:  Jundishapur J Microbiol       Date:  2016-05-09       Impact factor: 0.747

Review 6.  Pharyngitis.

Authors:  Ruth Weber
Journal:  Prim Care       Date:  2013-11-21       Impact factor: 2.907

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.